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A B S T R A C T
Background
Since pulmonary artery balloon flotation catheterization was first introduced in 1970, by HJ Swan and W Ganz, it has been widely
disseminated as a diagnostic tool without rigorous evaluation of its clinical utility and effectiveness in critically ill patients. A pulmonary
artery catheter (PAC) is inserted through a central venous access into the right side of the heart and floated into the pulmonary artery.
PAC is used to measure stroke volume, cardiac output, mixed venous oxygen saturation and intracardiac pressures with a variety of
additional calculated variables to guide diagnosis and treatment. Complications of the procedure are mainly related to line insertion.
Relatively uncommon complications include cardiac arrhythmias, pulmonary haemorrhage and infarct, and associated mortality from
balloon tip rupture.
Objectives
To provide an up-to-date assessment of the effectiveness of a PAC on mortality, length of stay (LOS) in intensive care unit (ICU) and
hospital and cost of care in adult intensive care patients.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 12); MEDLINE
(1954 to January 2012); EMBASE (1980 to January 2012); CINAHL (1982 to January 2012), and reference lists of articles. We
contacted researchers in the field. We did a grey literature search for articles published until January 2012.
Selection criteria
We included all randomized controlled trials conducted in adults ICUs, comparing management with and without a PAC.
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Data collection and analysis
We screened the titles and abstracts and then the full text reports identified from our electronic search. Two authors (SR and MG)
independently reviewed the titles, abstracts and then the full text reports for inclusion. We determined the final list of included studies
by discussion among the group members (SR, ND, MG, AK and SC) with consensus agreement. We included all the studies that
were in the original review. We assessed seven domains of potential risk of bias for the included studies. We examined the clinical,
methodological and statistical heterogeneity and used random-effects model for meta-analysis. We calculated risk ratio for mortality
across studies and mean days for LOS.
Main results
We included 13 studies (5686 patients). We judged blinding of participants and personnel and blinding of outcome assessment to
be at high risk in about 50% of the included studies and at low risk in 25% to 30% of the studies. Regardless of the high risk of
performance bias these studies were included based on the low weight the studies had in the meta-analysis. We rated 75% of the studies
as low risk for selection, attrition and reporting bias. All 13 studies reported some type of hospital mortality (28-day, 30-day, 60-day
or ICU mortality). We considered studies of high-risk surgery patients (eight studies) and general intensive care patients (five studies)
separately as subgroups for meta-analysis. The pooled risk ratio (RR) for mortality for the studies of general intensive care patients was
1.02 (95% confidence interval (CI) 0.96 to 1.09) and for the studies of high-risk surgery patients the RR was 0.98 (95% CI 0.74 to
1.29). Of the eight studies of high-risk surgery patients, five evaluated the effectiveness of pre-operative optimization but there was no
difference in mortality when these studies were examined separately. PAC did not affect general ICU LOS (reported by four studies) or
hospital LOS (reported by nine studies). Four studies, conducted in the United States (US), reported costs based on hospital charges
billed, which on average were higher in the PAC groups. Two of these studies qualified for analysis and did not show a statistically
significant hospital cost difference (mean difference USD 900, 95% CI -2620 to 4420, P = 0.62).
Authors’ conclusions
PAC is a diagnostic and haemodynamic monitoring tool but not a therapeutic intervention. Our review concluded that use of a PAC
did not alter the mortality, general ICU or hospital LOS, or cost for adult patients in intensive care. The quality of evidence was high
for mortality and LOS but low for cost analysis. Efficacy studies are needed to determine if there are optimal PAC-guided management
protocols, which when applied to specific patient groups in ICUs could result in benefits such as shock reversal, improved organ function
and less vasopressor use. Newer, less-invasive haemodynamic monitoring tools need to be validated against PAC prior to clinical use in
critically ill patients.
P L A I N L A N G U A G E S U M M A R Y
Pulmonary artery catheters for adult patients in intensive care
A pulmonary artery catheter (PAC) is a device utilized in intensive care units (ICU) to measure the pressures in the heart and lung
blood vessels and to monitor patients. The catheter is inserted into the right side of the heart through a line placed in a large blood
vessel in the neck or groin and is positioned into the pulmonary artery. Complications are uncommon and are mainly related to line
insertion. Occasionally bleeding inside the lung and changes in heart rhythm have been reported, but death associated with a PAC is
rare. The objective of this systematic review was to provide an up-to-date assessment of evidence on the effectiveness of PAC on death
rates, days spent in ICU, days spent in hospital, and cost of care for adult ICU patients.
We identified 13 studies comparing patients treated with and without the use of a PAC that studied a total of 5686 patients. These
were studies of patients undergoing routine major surgery (eight) and studies of patients who were critically ill and admitted to ICUs
(five). We analysed the studies for any trial related risks and performed appropriate statistical analysis to minimize any risk of bias or
errors. The quality of evidence is high from this review and further research is very unlikely to change our confidence in the estimate
of effect except for cost analysis.
Our review found that there were no differences in the number of deaths during hospital stay, days spent in general ICUs, and days
spent in hospital between patients who did and did not have a PAC inserted. Two US studies were analysed for hospital cost associated
with or without a PAC and showed no difference in the cost. Neither group of patients studied showed any evidence of benefit or harm
from using a PAC. The catheter is a monitoring tool that helps in diagnosis and is not a treatment modality. Insertion of PACs to help
make treatment decisions in ICU patients should be individualized and should be done by experts in the field after adequate training
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in the interpretation of data. Studies need to be conducted to identify subgroups of ICU patients who can benefit, when the device is
used in combination with standardized treatment plans, in reversing shock states and improving organ function.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Pulmonary artery catheter for adult patients in intensive care
Patient or population: Adult patients in intensive care
Settings: Intensive care unit
Intervention: Pulmonary artery catheter
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Pulmonary artery
Catheter
ICU length of stay (gen-
eral intensive care pa-
tients)
Follow-up: mean 10-12
days
The mean ICU length of
stay (general intensive
care patients) in the inter-
vention groups was
0.5 higher
(0.44 to 0.55 higher)
2723
(4 studies)
⊕⊕⊕⊕
high
Hospital length of stay
(general intensive care
patients)
Follow-up: mean 14-22
days
The mean hospital length
of stay (general intensive
care patients) in the inter-
vention groups was
0.8 lower
(2.71 lower to 1.12
higher)
1689
(2 studies)
⊕⊕⊕⊕
high
Hospital length of stay
(high-risk surgical pa-
tients)
Follow-up: mean 10-22
days
The mean hospital length
of stay (high-risk surgical
patients) in the interven-
tion groups was
0.35 higher
(0.05 lower to 0.75
higher)
503
(5 studies)
⊕⊕⊕⊕
high
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Cost of care (hospital
charges, 1000s of US
dollars)
The mean cost of care
(hospital charges, 1000’s
of us dollars) in the inter-
vention groups was
0.9 higher
(2.62 lower to 4.42
higher)
191
(2 studies)
⊕⊕©©
low1
Combined mortality of
all studies
Follow-up: mean 28-60
days
Study population RR 1.01
(0.95-1.08)
5686
(13 studies)
⊕⊕⊕⊕
high
297 per 1000 301 per 1000
(273 to 333)
Moderate
95 per 1000 97 per 1000
(85 to 110)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the
comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Only 2 studies reported the hospital cost out of 5, in 1990 to 91. The applicability in present situation after 20 years is questionable.
The cost cannot be compared across various countries.
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B A C K G R O U N D
Description of the condition
The concept of right heart catheterization was first introduced by
Dr Warner Forrsmann in 1929 (Chatterjee 2009). It was in 1970
that Dr HJ Swan and Dr William Ganz introduced the flow-di-
rected balloon-tipped catheter that led to a paradigm shift in the
way right heart catheterizations are performed at the bedside using
intracardiac pressure tracings, without utilizing fluoroscopic guid-
ance. Since then, the pulmonary artery catheter (PAC), also called
a Swan-Ganz catheter, has been utilized in the management of in-
tensive care unit (ICU) patients for the past 42 years (Swan 1970).
A PAC provides the intensivist with critical haemodynamic data
that includes cardiac output, mixed venous oxygen saturation, in-
trapulmonary and intracardiac pressures. These variables together
with additional derived variables calculated from these measure-
ments, such as pulmonary and systemic vascular resistance, right
and left ventricular stroke work indices, right and left ventricular
end-systolic and end-diastolic indices, right ventricular ejection
fraction, arterial and venous oxygen content, oxygen consump-
tion, oxygen delivery and oxygen extraction ratio, are used to guide
treatment of critically ill patients. On average, in the United States
(US) one million PACs were used annually in the 1990s (Connors
1996).
Description of the intervention
A PAC is a diagnostic and haemodynamic monitoring tool. The
PAC is used by clinicians in adult medical ICUs, cardiac catheter-
ization laboratories and coronary care units (CCUs). It is used
for pre-operative optimization of haemodynamics, intra-opera-
tive monitoring and postoperative management of critically ill
patients, and in cardiothoracic surgery patients such as coronary
artery bypass graft (CABG, or bypass surgery) and valvular surg-
eries to guide therapy and differentiate various types of shock
states.
For the procedure, the balloon-tip catheter is floated through a
central venous access, through the right atrium and right ventricle
to the pulmonary artery and left in position to measure the filling
pressures of the heart. When the balloon is inflated it measures
pulmonary capillary wedge pressure or occlusion pressure, which
is an indirect measure of left ventricular end-diastolic pressure.
Newer PACs have the capability of measuring central venous oxy-
gen saturation and continuous cardiac output.
Insertion of a PAC requires a central venous access and its compli-
cations are mainly related to the line placement. Advanced train-
ing and ultrasound guidance of line insertions have reduced some
of these risks in recent years (Lamperti 2012). Long-term central
line related complications such as infections are not attributable
to PAC insertion. Additional risks of floating a PAC include pos-
sible pulmonary artery rupture and subsequent bleeding or pul-
monary infarction (lung tissue loss). In an attempt to review the
risk and benefits of a PAC the American Society of Anesthesiolo-
gist reviewed 860 publications. Though major morbidity related
to PAC seems uncommon, minor atrial and ventricular arrhyth-
mias (heart rhythm abnormalities) are common during catheter
insertion (>20%).
Complications from PAC can be classified as:
1. those from central venous access (arterial puncture, post-
operative neuropathy (pain and sensation deficit), air embolism
(air in blood vessels) and pneumothorax (air outside the lungs),
reported in less than 3.6%;
2. those arising from catheterization (severe dysrhythmias,
right bundle branch block and complete heart block), seen in
0.3% to 3.8%; and
3. those due to prolonged catheter residence (pulmonary
artery rupture, pulmonary infarction, venous thrombosis (clots
in vein)), in from 0.03% to 3%.
The task force states that overall deaths attributed to a PAC are
0.02% to 1.5% (ASA task force on PAC 2003).
How the intervention might work
Pulmonary artery catheters (PACs) were initially widely used by
cardiologists in themanagement of patientswith acute heart failure
or cardiac tamponade, major surgery patients with a cardiac his-
tory, and cardiogenic shock. The first data on PACswere published
in 1987, in an observational study from 16 different hospitals that
looked at time trends in incidence rates, on in-hospital and long-
term case fatality rates in patients with acute myocardial infarction
(Gore 1987). The study had 3000 patients and showed a sharp
rise in the use of PACs from 1975 to 1984 (7.2% to 19.9%) with
no difference in mortality in the group of patients with cardio-
genic shock. There was, however, increased mortality and hospital
length-of-stay (LOS) in patients with congestive heart failure and
hypotension who received a PAC. Interestingly, the study showed
better long-term survival in patients with cardiogenic shock who
received a PAC at six months and five years. In 1990, another non-
experimental study showed increased mortality in patients who
received a PAC (Zion 1990). In this study only 67 patients had a
PAC and the authors concluded that it was unlikely that the PAC
itself had led to the increased mortality. This led to the first ran-
domized controlled trial (RCT) of PACs in 1991 (Guyatt 1991).
The European Society of Intensive Care Medicine later came out
with a consensus document recommending the indications for use
of PACs (ESICM 1991).
In 1996, results of a prospective, non-experimental cohort study
that involved 5700 patients with nine different illnesses, of which
2100 received PACs, showed increased mortality with PAC use
(Connors 1996). The publication sparked a lot of controversy pri-
marily because it was a non-randomized comparison (Assoc. Press
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1996). A Consensus Statement issued by the Society of Critical
Care Medicine identified that the published evidence to support
the use of PAC was paltry and scientifically very poor, and the
need for clinical trials was highlighted (PAC Consensus 1997).
Recent evidence suggests that use of a PAC and therapy based
on the information obtained reduces surgical morbidity and mor-
tality (Brienza 2009; Gurgel 2011; Hamilton 2011). Until now,
controversy exists with the use of PACs in various clinical settings
in ICUs. If clinicians acquire adequate knowledge and expertise,
PAC data and monitoring may be valuable to guide therapy in
critically ill patients. The device has to produce data that are re-
liably interpreted by attending staff. These data are usually not
available from other sources and can lead to a change in therapy
that is linked to improved outcomes. The therapies that might be
altered or added include pressors, inotropes, vasodilators, fluids,
diuretics and lusitropic agents.
Why it is important to do this review
This is an update of a Cochrane review first published in 2006
(Harvey 2006) about PAC use in adult ICU. The initial review
identified 12 studies and the main findings were that PAC did not
affect the mortality of patients, hospital or ICU LOS, and the cost
based on charges billed to the patients were on average higher in
the PAC groups.
Since the adoption of the PAC into clinical practice, several
observational studies and five RCTs involving general ICU pa-
tients (Binanay 2005; Harvey 2005; NHLBI 2006; Rhodes 2002;
Richard 2003) have been conducted to determine its effect on pa-
tient mortality. These studies did not show a benefit of the use of
a PAC in patient outcomes. There was significant negative pub-
licity, especially in the US, leading to a decline in the use of PACs
in clinical practice. A report looking at trends in the use of PACs
in the US, published in 2007 (Wiener 2007), reported a 65% re-
duction in its use among medical ICUs and 63% reduction in its
use among surgical ICUs from 1993 to 2004. Recently, however,
there has been criticism in the way the data from these studies
were interpreted (Greenberg 2009). Authors have argued that the
PAC is a monitoring device and that mortality must not be a ba-
sis for determining the efficacy of monitors. Patient outcomes are
not dependent upon insertion of a PAC; outcomes are dependent
upon appropriate interpretation of acquired data followed by ad-
ministration of appropriate care. It has also been argued that stud-
ies were not adequately powered to provide conclusions on rare
outcomes like patient mortality (Greenberg 2009). Also, it would
have been challenging to adequately blind physicians to the PAC,
as it is hard to conceal the presence of a PAC in a patient.
The timeliness of institution of care with regard to PAC insertion
has also been questioned. In a meta-analysis performed in 1996
(Cooper 1996) that showed no benefit of goal-directed therapy
using a PAC in a general ICU population, only one study was con-
sidered of high quality (Gattinoni 1995). The study randomized
762 patients in one of three categories, cardiac index (CI) 2.5 to
3.5 ml/min/m2; CI > 4.5 ml/min/m2; and central venous oxygen
saturation > 70%. The patients in the study, however, did not re-
ceive the PAC until up to 72 hours after development of shock.
The patients in the most recent Fluid and Catheter Treatment
Trial (FACTT) (NHLBI 2006) that studied the safety and effi-
cacy of PAC-guided versus central venous pressure (CVP)-guided
treatment of patients with acute lung injury also did not receive
therapy until a mean of 25 hours after establishment of diagnosis.
In the light of the aforementioned studies and meta-analysis, and
the ongoing debate on appropriate use of the PAC, the purpose
of the current systematic review was to search for all the available
evidence from RCTs and to define the best evidence base for cur-
rent clinical practice.
O B J E C T I V E S
To systematically search for and synthesize all the evidence from
randomized controlled trials (RCTs) that utilized pulmonary
artery catheters (PACs) in the management of critically ill patients
in the intensive care units (ICUs) and analyse the effect of the PAC
on mortality, length of stay and cost of care.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included RCTs with or without blinding. We placed no limi-
tation on the language of publication.
Types of participants
We included studies with more than 50% adult patients (16 years
of age and above) where a PAC was placed in an ICU setting (see
definition below) or placed during a surgical procedure leading to
ICU admission.
We defined an ICU as including: an intensive care unit (ICU); a
paediatric intensive care unit; a high dependency unit (HDU); a
postanaesthesia care unit (PACU); or a service-specific critical care
unit (CCU).
We excluded studies that included patients in whom death had
been declared using brain stem death criteria and who had a PAC
placed solely for organ support prior to organ donation.
We excluded studies comparing PAC with the new less invasive
techniques used to measure the haemodynamic parameters, such
as continuous pulse contour cardiac analysis (PiCCO).
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Types of interventions
We included RCTs in which patients treated in an ICU were ran-
domized to be managed with a PAC (of any type) in one arm of
the trial and without a PAC in another arm.
Types of outcome measures
Primary outcomes
1. All types of hospital mortality (28 days, 30 days, 60 days or
ICU mortality)
Secondary outcomes
1. Length of stay (LOS) in ICU
2. LOS in hospital
3. Costs of hospital care
Search methods for identification of studies
Electronic searches
We searched the Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2011, Issue 12), see Appendix
1 for the search strategy; MEDLINE (OvidSP) (1954 to January
2012), see Appendix 2; EMBASE (OvidSP) (1980 to January
2012), see Appendix 3; CINAHL (EBSCOhost) (1982 to January
2012), see Appendix 4.
Searching other resources
Grey literature search
We searched the grey literature including NYAM Grey Litera-
ture Collection, OAIster - Digital Resource from Open Archive
Collections, Directory of Open Access Journals and OpenDOAR;
clinical trial registers (International Standard Randomised Con-
trolled Trial Number Register, Eur Clinical Trials Register (new
2011) and WHO International Clinical Trial Registry Platform);
dissertations and theses; open access journals; meeting abstracts
and conference abstracts (handsearched for original review). See
Appendix 5 to see a list of all resources and terms.
Previous reviews
We reviewed the studies cited in the previously published review
(Harvey 2006), now updated in 2012.
Manual searches
We handsearched conference abstracts from the four major Euro-
pean and North American annual critical care conferences, run by
the European Society of Intensive Care Medicine, the Society of
Critical Care Medicine (US), the American Thoracic Society, and
the Erasme Hospital, Free University of Brussels (from 1995 to
2001). For the update we added the above grey literature search
in 2012 (see Appendix 5).
Citation review
We checked the references lists of included citations and poten-
tially relevant citations, identified from the electronic searches, for
further relevant studies. We also checked the reference lists of any
systematic or narrative reviews identified from the searches.
Experts
We contacted key people in the field of critical care, including
clinicians and other researchers, to identify relevant studies.
Industry
We contacted relevant pharmaceutical and equipment companies
for published and unpublished reports to identify relevant studies.
Data collection and analysis
Selection of studies
In the updatewe included all the originally selected studies (Harvey
2006) and added new studies searched for from April 2005 to
January 2012. Four authors screened the updated search results
independently (SR, ND,MG and AK).One author (SC) searched
the grey literature. We obtained the full text articles of the stud-
ies that seemed to be relevant during our screening. We resolved
discrepancies through discussion.
Data extraction and management
Two authors independently reviewed the full text reports of each
included study (update in 2012 by SR or MG, AK; and original
review (Harvey 2006) in 2006 by SH, DY or WB, KR) and ex-
tracted the following data:
• general information, including title, lead author, journal,
publication details and name of reviewer;
• study characteristics, including verification of study
eligibility, characteristics of study population, risk of bias of
included studies and interventions;
• outcome measures and results, including length of follow-
up, drop-outs and measures of effect.
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We resolved differences in the data extracted between the two au-
thors by discussion. We documented the reasons for excluding
studies. Two authors (SH and DY) double-entered data into Re-
view Manager in the original version (Harvey 2006). In the 2012
update two authors (SR and MG) independently extracted the
data and created risk of bias tables. We resolved the discrepancies
through discussion. Two authors (SR and ND) entered data into
Review Manager (RevMan 5.1).
Assessment of risk of bias in included studies
We used the Cochrane Handbook for Systematic Reviews of Interven-
tions (the Handbook) (Higgins 2011) to assess the risk of bias for
each study. Two authors (SR andMG) independently assessed the
risk of bias for each study considering the following seven domains
for bias: random sequence generation (selection bias), allocation
concealment (selection bias), blinding of participants and person-
nel (performance bias), blinding of outcome assessment (detection
bias), incomplete outcome data (attrition bias), selective reporting
(reporting bias) and other bias. For each bias we expressed our
judgement as: at high risk (plausible bias that seriously weakens
confidence in the results), low risk (unlikely to seriously alter the
results) and unclear risk (raises some doubt about the results) of
bias. We also gave the reason for our judgement. Three authors
(SR, MG and AK) resolved disagreements by reviewing the data
together.
We agreed that complete blinding of the treating physicians may
not be feasible at the bedside, but the investigator could be blinded.
If the investigator was blinded or did not participate in patient
care, we agreed that those studies were at low risk for performance
bias. If it was a single centre study and investigators and the treating
physicians were the same person, we agreed that performance bias
was at high risk. We agreed that blinding of outcome assessment
was feasible in studies such as in a multicentre trial if the outcome
assessor did not participate in patient care.
Measures of treatment effect
For dichotomous data (mortality), we used risk ratio (RR) as the
summary measure. For continuous data (LOS, cost of care) we
used mean difference as the summary measure.
Unit of analysis issues
We also combined studies that had included other interventions
in addition to the PAC in a separate subgroup analysis. For studies
that had two PAC intervention groups, we combined the two
groups.
Dealing with missing data
We did not contact any original investigators to request informa-
tion about missing data. Our search was comprehensive and miss-
ing studies was unlikely. One study (Bender 1997) did not report
all the details of the outcome measures postoperatively for the
control group and we judged the study as at high risk of selective
reporting bias in the analysis.
Assessment of heterogeneity
WeusedChi2 test (χ2) to assess whether observed differences in re-
sults were compatible with chance alone. A large Chi2 statistic rel-
ative to its degree of freedom provides evidence of heterogeneity of
intervention effects (variation in effect estimates beyond chance).
For quantifying inconsistency we used the I2 statistic to describe
the percentage of the variability in effect estimates that was due to
heterogeneity rather than sampling error (chance). An I2 of 0%
to 40% might not be important, 30% to 60% was moderate het-
erogeneity, 50% to 90% was substantial heterogeneity and 75%
to 100% was interpreted as considerable heterogeneity (Higgins
2011). When the heterogeneity was low in the outcome measures
meta-analysis was considered appropriate.
Clinical heterogeneity was explored by conducting subgroup anal-
ysis. To incorporate heterogeneity among studies random-effects
model meta-analysis was used. We did not exclude any studies
based on conflicting results, which minimized heterogeneity. We
performed sensitivity analysis with and without any potential out-
lying studies. We did not perform meta-regression to investigate
heterogeneity in a subgroup analysis due to low sample size of the
subgroups.
Assessment of reporting biases
We tried to minimize the impact of publication bias through
a thorough review of all the published data and grey literature.
We dealt with location bias by searching MEDLINE, EMBASE,
CENTRAL, CINAHL and grey literature using a variety of search
terms. We assessed publication bias using a funnel plot for the
combined mortality outcome.
Data synthesis
We summarized the aims, methods and outcome measures of in-
terest (mortality, LOS in ICU and hospital, and costs of care).
We expressed mortality as absolute numbers and percentages, and
we expressed LOS as mean, median, and range for survivors and
non-survivors reported separately. The primary outcome measure
of interest was in-hospital mortality at any time; if this was not
reported, we used the mortality at the point closest to hospital
discharge. We expressed results on costs of care in a range of mea-
sures. The secondary outcome measures were ICU and hospital
LOS and cost of care.
We calculated risk ratio (RR) for mortality across studies and
mean days for LOS using a random-effects model in RevMan 5.1
(Higgins 2011; RevMan 5.1). All analyses were based on the in-
tention-to-treat principle. Among the five studies that reported
various costs, only two studies reported the hospital cost and a
fixed-effect model was used to analyse the cost.
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One study (Pearson 1989) allowed patients to cross-over to the
PAC group after randomization due to ethical reasons. We com-
bined the number of patients in the PAC group for mortality
analysis and reported the hospital LOS separately. Another study
(Guyatt 1991) allowed sicker patients to cross-over to the PAC
group. We did not perform paired-analysis due to the low number
of recruitments. The weights of these two studies were low in the
meta-analysis.
Subgroup analysis and investigation of heterogeneity
Patients admitted to ICU are a heterogeneous group in terms of
diagnosis, prognosis and resource utilization. This heterogeneity
exists both among patients within a single ICU and among the case
mix of patients admitted to medical and surgical ICUs. Therefore,
we performed subgroup analysis combining data from studies that
had included patient populations with similar characteristics. We
did subgroup analysis of mortality separately in general intensive
care patients, high-risk surgical patients, and studies of perioper-
ative monitoring to investigate the effect of the heterogeneity of
the studies. We analysed ICU LOS and hospital LOS separately
for surgical and medical patients.
Sensitivity analysis
We performed sensitivity analysis to examine the impact of studies
which had a high risk of bias. This was achieved by removing a
study from the meta-analysis and analysing the effect of removing
that study on overall mortality. We performed a similar sensitivity
analysis with hospital LOS and ICU LOS with studies that had a
high risk of bias.
R E S U L T S
Description of studies
Results of the search
We identified a total of 4521 citations (3800 in 2006 (Harvey
2006) and 721 in 2012) (Figure 1). After screening by title and
then abstract, we obtained full paper copies for 46 (41 in 2006 and
five in 2012) citations that were potentially eligible for inclusion
in the review. Of these, 28 did not fulfil our inclusion criteria and
were excluded for the reasons described in the table Characteristics
of excluded studies.
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Figure 1. PAC for adult patients intensive care study flow diagram.O - Original review in 2006. U - Updated
review in 2012.
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Included studies
We included 13 RCTs. These 13 studies enrolled a total of 5686
patients. All patients were admitted to ICU and randomized to
either a PAC group or control group with or without a central
venous catheter (CVC) to monitor haemodynamics. All RCTs
reported hospital mortality as the primary outcome (Analysis
1.1) and some reported ICU LOS and hospital LOS as secondary
outcomes (Characteristics of included studies). The studies fell
broadly into two groups, as follows.
1. General ICU studies: we included five studies of general in-
tensive care patients with varying diagnoses (acute lung injury
(NHLBI 2006); acute ventilatory failure (Guyatt 1991); shock
(Rhodes 2002; Richard 2003)); and one study of patients admit-
ted to the ICU requiring PAC insertion as deemed appropriate by
the attending physician (Harvey 2005).
2. High-risk surgery studies: we included eight studies of patients
undergoing high-risk surgery. These studies were divided into two
subgroups.
a) Studies investigating the effectiveness of preoperative optimiza-
tion of haemodynamics. We identified five studies in this cate-
gory, for vascular surgery (Bender 1997; Berlauk 1991); abdom-
inal, thoracic, vascular or orthopaedic surgery (Sandham 2003);
abdominal reconstructive surgery (Valentine 1998); and prede-
fined high-risk surgical patients (Shoemaker 1988).
b) Studies comparing the effectiveness ofmanagingpatients during
the perioperative period where patients were admitted to the ICU
following surgery. We identified three studies in this category, in
aortic reconstruction (Isaacson 1990; Joyce 1990) and elective
cardiac surgery patients (Pearson 1989).
Excluded studies
We excluded non-RCTs and systematic reviews. We also excluded
RCTs that compared PACs with non-invasive haemodynamic
monitoring methods and studies that had their primary outcome
of interest as fluid management (see Characteristics of excluded
studies).
Risk of bias in included studies
We analysed seven domains of potential risk of bias for the in-
cluded studies (Figure 2). We rated blinding of participants and
personnel and blinding of outcome assessment at high risk in half
of the included studies and at low risk in one third of the studies.
Regardless of the high risk of performance bias, these studies were
included because of the low weight of the studies in themeta-anal-
ysis. We rated three quarters of the studies at low risk of selection
bias, attrition bias and reporting bias (Figure 3). We performed
a sensitivity analysis by removing all the trials that had high and
unclear risk of bias and the results remained the same. Publication
bias appeared to be unlikely as the funnel plot is symmetric, which
also confirms the absence of effect of study size on the outcome
(Figure 4).
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 4. Funnel plot of comparison: 5 PAC versus no PAC outcome: 5.1 Combined mortality of all studies.
Allocation
Nine studies clearly used adequate randomization and conceal-
ment schemes and were classified as low risk for bias (Guyatt 1991;
Harvey 2005; Isaacson 1990; Joyce 1990, Pearson 1989; Rhodes
2002; Richard 2003; Sandham 2003; Shoemaker 1988). Three
studies had an unclear risk due to not reporting allocation details
(NHLBI 2006; Valentine 1998) and inconsistent methods of al-
location (Berlauk 1991). One high-risk study did not follow any
acceptable methods (Bender 1997).
Blinding
Performance bias
The intervention under study, management with a PAC (with or
without preoperative optimization), meant that it was not feasible
to completely blind the study participants and some study person-
nel to the assigned treatment group. However, if treating physi-
cians and patient care decision makers were not the investigators,
performance bias could be minimized.
Four studies were at low risk for blinding of participants or per-
formance bias due to the multicentre nature of the study or in-
vestigators were not the providers (Harvey 2005; Rhodes 2002;
Richard 2003; Sandham 2003). Five studies were at high risk for
performance bias. One study, even though a multicentre trial, was
protocol driven and allowed the PAC patients to change over to a
CVC at the discretion of the treating physician (NHLBI 2006).
In two studies the providers were the investigators (Isaacson 1990;
Shoemaker 1988) and in two other studies the providers were al-
lowed to change the group or cross-over to PAC after randomiza-
tion (Guyatt 1991; Pearson 1989).
Three studies gave insufficient information to assess performance
bias (Berlauk 1991; Joyce 1990; Valentine 1998) (Figure 3).
Detection bias
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The nature of the intervention under study meant that complete
blinding of outcomewas not feasible, however detection bias could
beminimized if the investigator and treating physician were differ-
ent personnel. Performance bias and detection bias shared similar
high and unclear risks in all the studies except in one study. Berlauk
et al (Berlauk 1991) had low risk because investigators (anaesthe-
siologists) were involved for a short period of the first 18 hours
only and were unlikely to have influenced themortality or hospital
LOS thereafter. Two studies gave insufficient information and the
risk was unclear (Joyce 1990; Valentine 1998). Four studies were
at low risk (Harvey 2005; Rhodes 2002; Richard 2003; Sandham
2003). Four other studies were at high risk (Guyatt 1991; Isaacson
1990; Pearson 1989; Shoemaker 1988) however, given their low
weights in the meta-analyses, the impact on the effect estimate of
removing them would have been negligible. The FACTT study
(NHLBI 2006) was at high risk for detection bias because only
weaning of vasopressors were under protocol management and not
fluid management, which may have influenced the mortality and
LOS outcomes.
Incomplete outcome data
For all studies the number of patients withdrawn following ran-
domization was low (0 to 3) and they were at low risk for attri-
tion bias except one study, which did not report on one group of
patients and the risk was unclear (Bender 1997). Another study
had a higher number of withdrawals (13 in PAC group and 14 in
CVC group) (Harvey 2005).
Selective reporting
All the studies were free of selective reporting bias except one
(Bender 1997). We judged this study as high risk for reporting
bias due to it not reporting any postoperative PAC group data.
The study was of preoperative PAC monitoring, but one group
of patients had a PAC postoperatively and this data may have
impacted on the outcome.
Other potential sources of bias
Five studies had high risk for unknown bias. There was a high
rate of cross-over from the control to the PAC group for two stud-
ies. In one study eight out of 17 patients allocated to the control
group (47%) were subsequently managed with a PAC (Guyatt
1991). Allowing sicker patients to cross-over to the PAC group
after randomization may have contributed to the high mortality
in the PAC group. The other study had both high-risk and low-
risk surgical patients, and 17 (57%) crossed-over to a PAC dur-
ing the postoperative period when the physicians felt that the pa-
tient needed invasive monitoring (Shoemaker 1988). One study
had three groups initially and the additional groups four and five
were included after randomization (Pearson 1989). Bender et al
(Bender 1997) reported that one surgical intensivist cared for 104
patients and did not report the number of patients accounting for
the LOS of 27 days. The FACCT (NHLBI 2006) study random-
ized the patients to a PAC or CVC group and at the same time
applied another strategy of randomization to the same patients to
a conservative or liberal fluid therapy group.
Effects of interventions
See: Summary of findings for the main comparison Pulmonary
artery catheter for adult patients in intensive care
Mortality
Overall, four studies (Harvey 2005; Isaacson 1990; Sandham
2003; Shoemaker 1988) reported any hospital mortality. The re-
maining studies reported 28-day mortality (Rhodes 2002; Richard
2003); 30-day mortality (Bender 1997; Joyce 1990); 60-day mor-
tality (NHLBI 2006); or ICU mortality (Pearson 1989). Three
studies did not specify the type of mortality statistics (Berlauk
1991; Guyatt 1991; Shoemaker 1988). The combined mortality
outcome for all studies, with 5686 patients, was not significantly
different (P = 0.73) between the PAC and CVC groups (RR 1.01,
95% CI 0.95 to 1.08) (heterogeneity Tau² = 0.00; Chi² = 5.26, df
= 11 (P = 0.92); I² = 0%) (Analysis 1.1; Figure 5; Figure 6). The
overall outcome did not change with sensitivity analysis, by elim-
inating any single study. Large studies had almost similar weights
and smaller studies had similar low weights, and no single study
altered the weight of the analysis. To address the issue of analysing
the mortality at different time points, various sensitivity analyses
were conducted by removing groups of studies. Sensitivity analy-
sis done by keeping the four studies with 1021 patients that re-
ported only 28-day and 30-day mortality (Bender 1997; Joyce
1990; Rhodes 2002; Richard 2003) showed no difference in mor-
tality (RR 0.98, 95%CI 0.87 to 1.10). By removing the combined
28 and 30-day mortality studies, the remaining nine studies with
a total of 4665 patients also did not show any change in mortality
(RR 1.03, 95% CI 0.95 to 1.11). Combining eight studies with
3665 patients that reported hospital or ICU mortality at any time
point (sensitivity analysis done by removing theNHLBI study that
reported 60-day mortality in combination with the four studies
that reported 28 and 30-day mortality) also did not change any
mortality (RR 1.03, 95% CI 0.95 to 1.11).
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Figure 5. Forest plot of comparison: 5 PAC versus no PAC (combined medical and surgical patients),
outcome: 5.1 Combined mortality of all studies.
Figure 6. Forest plot of comparison: 1 PAC versus no PAC, outcome: 1.2 All types mortality (high-risk
surgical patients).
Mortality: general ICU studies
Data on 2923 patients enrolled into the five studies (Guyatt 1991;
Harvey 2005; NHLBI 2006; Rhodes 2002; Richard 2003) were
pooled to give a RR of 1.02 (95% CI 0.96 to 1.09) comparing
management with a PAC to management without a PAC (test for
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heterogeneity: Tau² = 0.00; Chi² = 1.04, df = 4 (P = 0.90); I² =
0%) (Analysis 2.1).
Mortality: high-risk surgery studies
Studies comparing mortality: preoperative optimization
(using a PAC) with standard preoperative care
The numbers of deaths in each group for the five studies (Bender
1997; Berlauk 1991; Sandham 2003; Shoemaker 1988; Valentine
1998) are detailed in ’All types of mortality (high-risk surgical
patients)’ (Figure 6). We pooled data on the 2395 patients (total
number, combined PAC and control groups) enrolled into these
studies, which yielded a RR of 0.98 (95% CI 0.74 to 1.29) com-
paring preoperative optimization with standard preoperative care
(test for heterogeneity: Tau² = 0.00; Chi² = 3.58, df = 4 (P = 0.47);
I² = 0%) (Analysis 2.2). Two studies (Berlauk 1991; Shoemaker
1988) had two PAC groups, which were combined for the pooled
analysis.
Studies comparing mortality: PACs with CVCs for
monitoring patients perioperatively
The number of deaths in each group for the three studies (Isaacson
1990; Joyce 1990; Pearson 1989) are detailed in ’All types of mor-
tality (high-risk surgical patients)’ (Figure 6). We pooled data on
the 368 patients enrolled into these studies to give a RR of 1.10
(95% CI 0.14 to 8.82) comparing management with and without
a PAC based on intention to treat (test for heterogeneity: Tau² =
0.00; Chi² = 0.79, df = 1 (P = 0.37); I² = 0%) (Analysis 2.2). One
study (Pearson 1989) had two PAC groups, which were combined
for the pooled analysis. Although a large proportion of patients
in this study were reallocated from the control group to one of
the two PAC groups, we analysed them as they were originally
allocated, that is in the control group.
Combining data from all the high-risk surgery studies gave a
pooled risk ratio of 0.98 (95% CI 0.74 to 1.29) (heterogeneity
Tau² = 0.00; Chi² = 4.37, df = 6 (P = 0.63); I² = 0%) (Analysis
2.2) (Figure 6).
ICU length of stay
Most studies reported the LOS in ICU for survivors and non-sur-
vivors combined (Appendix 6). Two studies (Joyce 1990; Sandham
2003) did not report the LOS in ICU.
ICU LOS: general ICU studies
General intensive care unit studies found no significant differences
between the treatment and control groups in ICU LOC. Four
studies with 2723 patients (Guyatt 1991; Harvey 2005; NHLBI
2006; Richard 2003) reported themean (standard deviation) LOS
in ICUanddatawere pooled to give ameandifference in days spent
in ICU of 0.50 (95% CI 0.44 to 0.55) comparing management
with a PAC tomanagement without a PAC (test for heterogeneity:
Tau² = 0.00; Chi² = 0.66, df = 2 (P = 0.72); I² = 0%) (Analysis
3.1).
ICU LOS: high-risk surgery studies
In high-risk surgery studies, four (Bender 1997; Berlauk 1991;
Shoemaker 1988; Valentine 1998) of the five studies of preopera-
tive optimization and one (Isaacson 1990) of the three studies of
perioperative monitoring only reported the mean LOS in ICU.
When data were pooled to analyse the mean difference (MD) in
days spent in ICU (MD 1.57 days, 95% CI 0.36 to 2.79) com-
paring management with PAC to without a PAC, the test of het-
erogeneity was extraordinarily high (heterogeneity Tau² = 1.77;
Chi² = 136.51, df = 4 (P = 0.00001); I² = 97%). Such high het-
erogeneity suggested that the combined high-risk surgery studies
were very dissimilar and therefore not appropriate for meta-anal-
ysis to compare the ICU LOS outcome in this subgroup.
Hospital length of stay
Overall, nine studies reported the LOS in hospital. Again, most
studies reported the LOS in hospital for survivors and non-sur-
vivors combined (Appendix 6). None of the studies found a sig-
nificant difference between the treatment groups. Shoemaker et al
(Shoemaker 1988) reported more days in hospital for all groups
compared with other studies of high-risk surgery patients.
Hospital LOS: general ICU studies
Two studies (Harvey 2005; Richard 2003) with a total of 1689
patients reported the mean (standard deviation) LOS in hospital.
Pooled data gave aMD in days spent in hospital of -0.80 (95%CI -
2.71 to 1.12) comparing management with a PAC tomanagement
without a PAC (heterogeneity Tau² = 0.34; Chi² = 1.09, df = 1 (P
= 0.30); I² = 9%) (Analysis 4.1; Appendix 6).
Hospital LOS: high-risk surgery studies
Five studies with a total of 503 patients reported hospital LOS.
Four (Bender 1997; Berlauk 1991; Shoemaker 1988; Valentine
1998) of them were preoperative optimizations and one (Isaacson
1990)was a study of perioperativemonitoring, reporting themean
(standard deviation) LOS in hospital. Pooled data gave a MD in
days spent in hospital of 0.35 (95% CI -0.05 to 0.75) comparing
management with and without a PAC (heterogeneity Tau² = 0.00;
Chi² = 3.54, df = 4, (P = 0.47); I² = 0%). For two studies, which
had two PAC groups, a weighted mean (and standard deviation
(SD)) hospital LOS was used (Berlauk 1991; Shoemaker 1988)
(Analysis 4.2).
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Cost
Four studies (Berlauk 1991; Isaacson 1990; Pearson 1989;
Shoemaker 1988), all conducted in the US, collected data on costs
of care based on hospital charges (Appendix 7) (the units shown
are 1000 USD). Pearson et al (Pearson 1989) used the mean of
the total cost, which was the amount actually billed to the pa-
tient. Information was also given about specific costs of arterial
blood gas measurement, cardiac output measurements, and mea-
surement of haemoglobin and haematocrit. Only the total costs
have been included in this review. They reported that the mean
costs per patient were significantly higher for the mixed venous
oxygen saturation (SvO2) PAC group compared with the standard
PAC group, although the P value was not given. The costs given
in the table (Appendix 7) for the control group excluded the 46
patients reassigned after randomization, which were as follows: re-
assigned to management with standard PAC (n = 33), mean total
cost (SD) USD 986 (578) (USD 1068.28 for 2011, Cochrane
cost converter); reassigned to management with SvO2 PAC (n
= 13), mean total cost (SD) USD 1126 (382) (USD 1219.97
for 2011, Cochrane cost converter). In addition to the hospital
charges, Isaacson et al (Isaacson 1990) reported the professional
fees charged by the anaesthesiologists per patient in each group
and found that the fees were significantly higher per patient in the
PAC group (P = 0.0001) compared with the control group.
For the meta-analysis, it was not appropriate to combine hospital
costs with physician costs as there are physician charges specifically
for insertion of a PAC.We excluded two studies from the subgroup
analysis: the study by Pearson et al (Pearson 1989), for reasons
described earlier, and the study by Shoemaker et al (Shoemaker
1988) because the SD was not reported. Therefore, data from
two studies with a total of 191 patients (Berlauk 1991; Isaacson
1990) that reported hospital costs were combined with a fixed-
effect model (MD 0.90, 95% CI -2.62 to 4.42) (Analysis 5.1).
D I S C U S S I O N
Summary of main results
We identified 13 RCTs with 5686 patients assessing mortality,
hospital and ICU LOS and cost effectiveness of PAC in ICUs
(Summary of findings for the main comparison). Five of these
studies investigated the clinical effectiveness of PACs in the man-
agement of general intensive care patients. The remaining eight
studies studied high-risk surgical patients. Of these surgical pa-
tients, five trials investigated whether preoperative optimization
of haemodynamics improved patient outcomes (Bender 1997;
Berlauk 1991; Sandham 2003; Shoemaker 1988; Valentine 1998).
In these studies, placement of a PAC was part of a package of care
that also included admission to ICU preoperatively and optimiza-
tion of haemodynamics to predetermined goals. Because patients
admitted to ICU are a heterogeneous group, we performed sub-
group analysis for studies of elective high-risk surgery patients (pe-
rioperative monitoring with and without preoperative optimiza-
tion) and studies of general intensive care patients. Studies which
had the potential for some aspects of high risk of bias had low
weight due to small numbers of patients and were included be-
cause of their limited effect on the meta-analyses.
We could not demonstrate any beneficial or harmful effects of
PACs onmortality, hospital LOS and cost of care in either patients
in general ICUs or a subgroup of high-risk surgical patients. Pul-
monary artery catheterization did not affect ICU LOS in general
intensive care unit patients (reported by four studies) or hospital
LOS (reported by nine studies).
A subgroup meta-analysis of five preoperative surgical studies sug-
gested that preoperative optimization guided by a PAC did not
improve or worsen the outcome in patients undergoing high-risk
surgery. This meta-analysis was heavily weighted (85.5% weight)
by the Sandham et al study (Sandham 2003) as this was the largest
RCT and had low risk for bias. Sensitivity analysis did not change
the mortality results. The overall mortality outcome was similar
in both the PAC group and the CVC group.
Four US based studies demonstrated that the overall hospital cost
billed for the PAC group was higher than for the CVC group. Two
of these studies qualified for analysis and did not show statistically
significant hospital cost differences.
Overall completeness and applicability of
evidence
The review question is ’Does the use of PAC in ICUs lead to in-
creased mortality, hospital or ICU LOS and cost?’. PAC is a diag-
nostic and monitoring tool, not a treatment intervention for any
given clinical condition. Use of PAC does not increase or decrease
mortality, ICU LOS or hospital LOS. It is appropriate to use in
selected patients, by intensive care physicians, as a diagnostic and
monitoring tool to guide patient care decisions. Cost effective-
ness varies among countries with different healthcare systems. Our
analysis on cost cannot be generalized or applied widely. This cur-
rent evidence is a complete review of all available RCTs to date.
It is unlikely that a large prospective RCT comparing PAC with
CVC will be published in the future. There are several less inva-
sive methods of haemodynamic monitoring, and their compari-
son with PAC is beyond the scope of this review. Regardless, the
applicability of this evidence of no effect on mortality is strong
in the ICUs. A PAC is however a diagnostic tool and its impact
on management must not be interpreted with regard to mortality
outcomes in adults in intensive care. Shock reversal, improvement
in organ dysfunction and less vasopressor use are other potential
outcome measures that need to be studied.
Barriers in evaluation of the PAC
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One of the main barriers to an effective evaluation of the PAC
in intensive care has been the lack of equipoise amongst inten-
sive care clinicians. The training, expertise in PACmeasurements,
utilization of PAC data for clinical decisions and management
of patients vary widely among clinicians. Iberti et al found that
providers have significant gaps in their knowledge and expertise in
utilizing PAC data (Iberti 1990; Iberti 1994). He reported, from
a study done in US and Canada, that the physician’s knowledge,
understanding, use and interpretation of PAC data were 67% cor-
rect, with a range of 19% to 100%. Mean scores varied by train-
ing, frequency of insertion and use of PAC data in patient treat-
ment (Iberti 1990). Among nurses the test scores of knowledge
and use of PAC were associated with years of experience in crit-
ical care, critical care registered nurse certification, responsibility
for repositioning and manipulating the catheter, frequency of use,
and self-assessed adequacy of knowledge (Iberti 1994). A simi-
lar study done in Australia utilizing the same questionnaire also
found that the test scores were significantly associated with years
of experience in intensive care, number of PACs inserted and the
physician’s certification (Johnston 2008).
The evidence is clear that physicians’ and nurses’ understanding of
PAC and its utility vary widely, making credentialing policies and
competency assessments essential. Lack of clinical expertise using
PACs may have played a role in patient outcomes in our meta-
analysis.
Use of the PAC in clinical practice
The PAC has been used in various clinical settings and our study
did not address its use in cardiac catheterization laboratories, coro-
nary care units or in cardiac pacing. One important use of the
PAC is to differentiate various types of shock and to guide therapy.
The objective of our analysis was not provider satisfaction, knowl-
edge and comfort level on using PAC; however, these are impor-
tant considerations in utilizing a diagnostic tool for accomplish-
ing clinically significant results. Lack of any significant mortality
improvement from PAC use can be attributed to several factors. A
diagnostic and monitoring device that has no therapeutic applica-
tions cannot modify outcomes unless the information gathered is
utilized appropriately. The aforementioned studies on physicians’
and nurses’ knowledge on PAC and its applicability, correct inter-
pretation of waveforms, effective utilization of the measured and
derived data, and management strategies based on the informa-
tion gathered vary widely. The significant decline in the clinical
utility of PAC in recent years may have caused poor training and
expertise, which could lead to occasional delayed utility during the
terminal stages of the disease process and improper interpretation
(Weiner 2007). Proper use of a PAC depends upon a thorough
understanding of factors contributing to measurement errors and
data interpretation. The PAC provides a wealth of potentially use-
ful haemodynamic information to the clinicians, and it is only
if this information is utilized correctly that it may be helpful in
patient management (Evans 2009).
Advantages of the PAC
During current clinical practice many clinicians still seek haemo-
dynamic data to manage critically ill patients. For this reason, a
variety of non-invasive monitoring devices have been introduced
and compared with PAC as the reference standard to evaluate
the test performance. PACs allowmeasurement of haemodynamic
variables that cannot be measured reliably or continuously by less
invasive monitoring devices (Evans 2009). The PAChas the added
benefit of being useful as a multilumen infusion port, in addition
to its utilization as a monitoring and data-gathering device. Crit-
ically ill patients require multiple drips and the current standard
of practice is to provide central venous access using a CVC. A
PAC is also placed through a central access and shares the same
short-term complications related to line insertion; however, it has
several advantages in addition to intracardiac monitoring. Newer
versions of PACs (for example Swan-Ganz flow-directed catheters)
provide rapid and effectivemonitoring of right heart pressures and
have the capability to measure mixed venous oxygen saturation,
perform cardiac pacing, and to assess the pulmonary vasculature
by injecting contrast media to do selective angiographic studies
(Edwards Lifesciences 2012). The studies included in our analysis
used a standard PAC.
The PAC also has a pivotal role in the measurement of central
venous oxygen saturation (ScVO2). The measurement of ScVO2
is crucial in the management of patients with severe sepsis and
septic shock (Rivers 2001). ScVO2 is obtained through the mea-
surement of oxygen saturation in venous blood returning to the
heart and is representative of the balance between oxygen delivery
and consumption. A recent study showed that both low and high
ScVO2 values obtained in the emergency department were associ-
ated with increased mortality in sepsis patients (Pope 2010) thus
underlining the importance of continuous ScVO2monitoring via
either a PAC or ScVO2 catheter.
Quality of the evidence
The quality of evidence from this review for the mortality out-
come in this population is robust. Using the Cochrane Grades
of Recommendation, Assessment, Development, and Evaluation
(GRADE) approach, the evidence was high for hospital and ICU
LOS but was low for cost analysis. Only RCTs were included in
the meta-analysis but many observational studies, meta-analyses
and systematic reviews, cohort studies, and grey literature were ex-
amined as sources to identify RCTs. A complete risk of bias anal-
ysis and sensitivity analysis minimized uncertainties and provided
concrete evidence based support. We had limitations in analysing
the secondary outcomes (hospital LOS, ICU LOS and cost) be-
cause only some of the studies reported them. This was particu-
larly so for cost effectiveness, which was reported in four studies.
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Weperformed subgroup analysis for general intensive care patients
and high-risk surgical patients, and the results did not vary sig-
nificantly. Overall, the internal validity and quality of evidence is
high (Summary of findings for the main comparison).
Potential biases in the review process
One potential bias is the fact that this is an update from a previous
review andmay have been influenced by previous conclusions. An-
other source of bias may be that the two groups of review authors
are from the same institution and may have similar backgrounds.
To overcome these potential biases four authors (SH, DY, WB
and KR) from the original review participated in the update. We
did not include studies that used PAC in other areas such as in
heart failure patients and coronary care units due to the inclusion
criteria and the different primary end points in the studies, but we
have included these details in the discussion.
Agreements and disagreements with other
studies or reviews
Evaluation of the clinical effectiveness of the PAC
Evaluation of the clinical effectiveness of managing general in-
tensive care patients with a PAC was addressed by the Fluid and
Catheter Treatment Trial (FACTT) (NHLBI 2006) and Pac-Man
studies (Harvey 2005); both are major clinical trials with relatively
low risks of bias. Both trials were adequately powered multicentre
RCTs with over 1000 patients each, in North America and Europe
(USA, Canada and UK). Their data on harms or complications of
PAC have been conflicting. The results of the FACTT suggested
an increased rate of complications from PAC insertion, as opposed
to the Pac-Man study which concluded no harm from PAC in-
sertion. The results do, however, agree with the findings of pre-
vious smaller studies (Guyatt 1991; Rhodes 2002; Richard 2003)
that PACs do not appear to confer survival advantage, nor do they
reduce hospital length of stay or costs of care. Both these trials
disagreed with the excess mortality findings reported by Connors
et al (Connors 1996) and showed that management with a PAC
did not worsen the outcome in critically ill patients.
Evaluation of efficacy of the PAC
FACTT (NHLBI 2006) was the only trial which evaluated the
efficacy of the PAC, but it did not address the ongoing debate as
to whether the use of a PAC as a diagnostic device and monitoring
tool can be responsible for adverse patient outcomes, especially
because it is not a therapeutic intervention. One may argue that
adverse outcomes may be related to complications of the proce-
dure, but rather they appear to be from inadequate training and
skills in utilizing the data and the lack of clinical expertise and
approved treatment protocols with the use of a PAC.
PAC monitoring coupled with therapy
There is mounting evidence for the preemptive strategy of haemo-
dynamic monitoring with a PAC coupled with therapy to reduce
surgical mortality and morbidity (Hamilton 2011). Hamilton et
al in their systematic review and meta-analysis of 29 trials involv-
ing 4805 patients that had perioperative haemodynamic manipu-
lation, which included a PAC with other interventions, reported
significantly reduced mortality (OR 0.43, 95% CI 0.33 to 0.78, P
= 0.0002) and surgical complications. Gurgel et.al performed an-
other meta-analysis of studies involving high-risk surgical patients
with the use of a PAC to maintain tissue perfusion (Gurgel 2011).
This study of 32RCTs comprising 5056 high-risk surgical patients
showed a significant reduction in mortality rate (odds ratio (OR)
0.67, 95 CI% 0.55 to 0.70, P < 0.00001) and postoperative organ
dysfunction when a haemodynamic protocol was used to main-
tain tissue perfusion. Brienza et al published a meta-analysis of 20
studies with 4220 patients and found that perioperative haemody-
namic optimization significantly reduced postoperative acute renal
injury and the need for renal replacement therapy (Brienza 2009).
These studies suggest that haemodynamic monitoring with a PAC
and intervention in surgical subgroups of patients have significant
clinical value, with improved organ dysfunction and mortality re-
duction.
Studies in agreement
A meta-analysis of major morbidities from 12 RCTs involving the
use of a PAC showed a very small reduction in morbidity with the
PAC (Ivanov 2000). Another meta-analysis that examined the re-
lationship of outcomes and resuscitation therapies showed that in
studies of severely ill patients, PAC insertion provided a mortality
benefit when haemodynamic optimization was performed prior
to organ failure, and that there were no differences in outcomes
when the PACwas utilized in less critically ill patients or following
the onset of multiorgan failure (Kern 2002). Similar results were
reported in a meta-analysis by Shah et al that used wider inclusion
criteria for studies including heart failure patients (mortality OR
1.04, 95% CI 0.9 to 1.2; and hospital LOS MD 0.11 days, 95%
CI -0.51 to 0.74) (Shah 2005). Two RCTs included in the Shah
meta-analysis were studies of perioperative monitoring. One study
showed no difference in mortality (Bonazzi 2002) and the other
study showed a significant reduction in mortality (2.9% in PAC
group versus 29% in controls) (Schultz 1985). The ESCAPE trial
had advanced heart failure patients who were admitted to coro-
nary care units and the therapeutic goals were different, looking
at the days alive out of hospital during the first six months, qual-
ity of life, biochemical and echocardiographic changes (ESCAPE
2005). These studies also concluded that PAC use did not change
the overall mortality.
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Cost effectiveness
Four of the 13 studies included a cost component based on hospital
charges to patients, and were conducted in US hospitals. One of
the problems with this approach is that specific charges vary across
hospitals, and patients may not be charged the same for the cost
of daily monitoring with a PAC. All the studies reported that, on
average, total costs were higher for patients managed with PACs
compared with those managed without. The cost effectiveness
evaluation for the PAC-Man study (Stevens 2005) provided data
based onUK practice. The primary outcome measure was quality-
adjusted life years (QALYs) and the secondary outcome measure
was hospital mortality. The authors concluded that withdrawal
of PACs from routine clinical use in ICUs within the NHS may
be considered cost effective. These cost effectiveness analyses of a
PAC compared to CVC cannot be broadly applied to the current
clinical practice. Cost varies across countries, regions, healthcare
systems and types of catheters used. Cost effectiveness cannot be
generalized to different populations, particularly for medical and
surgical patients.
Other haemodynamic monitoring devices
Clinicians are still looking for haemodynamic monitoring tools
without the known complications of the PAC. Newer cardiac out-
put catheters are already being used in ICUs to provide haemody-
namic measurements based on arterial contour power and pulse
power analyses. The examples of catheters which use a different
calibration scheme for measurement of cardiac output (CO) are
the lithium indicator dilution calibration system (LiDCO plus
TM ), which uses a transthoracic lithium dilution estimate of car-
diac output (CO) for calibration; PiCCO plusTM uses trans-tho-
racic thermodilution differences in arterial compliance; whereas
flow TracTM calculates CO from the pulse contour using a propri-
etary algorithm (Hadian 2007). These catheters cannot be used as
infusion ports, available with the PAC. These catheters are prefer-
ably inserted into a large calibre artery like the femoral artery,
which is again invasive and associated with complications, and are
attached to monitors which perform arterial power analysis and
pulse power analysis. The need for frequent recalibration is a po-
tential disadvantage of these newer techniques. These techniques
of measurement are relatively new and will require validation in
comparison to PAC in large-scale randomized trials for their ef-
fectiveness in therapy in ICUs.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review concentrated specifically on patients admitted to
ICUs. Thismeta-analysis concluded that use of a PAC alone, with-
out a properly designed therapeutic strategy based on haemody-
namic data, did not affect mortality, ICU LOS, hospital LOS or
cost in adult ICUs. It is important to note that the PAC itself is
a diagnostic and haemodynamic monitoring tool and not a ther-
apeutic intervention to achieve any major clinical outcomes. It is
not a harmful tool and may be used successfully for diagnostic and
haemodynamic monitoring in ICU patients by highly trained spe-
cialists (critical care physicians, cardiologists, anaesthesiologists)
with appropriate training in interpretation of the PAC variables,
and its applicability in specific clinical scenarios has been shown
in recent studies of surgical patients.
Implications for research
Efficacy studies are needed to determine if there are optimal, PAC-
guided management protocols which, when applied to specific
patient groups in ICUs, could result in benefit. Shock reversal,
improved organ dysfunction and vasopressor use are other poten-
tial outcome measures that need to be studied. In high-risk sur-
gical patients, preemptive haemodynamic monitoring with PAC
coupled with therapy has shown significant reduction in mortal-
ity and organ dysfunction (for example improved renal function)
in recent meta-analyses ( Brienza 2009; Gurgel 2011; Hamilton
2011).
One of the reasons that PAC use in general ICUs has been dimin-
ishing in recent years may be due to the increased availability of
sophisticated and less invasive devices to monitor cardiac output.
These are devices based on trans-oesophageal Doppler, lithium
dilution, pulse contour analysis, thoracic impedance and carbon
dioxide rebreathing. One explanation for the lack of benefit aris-
ing from PAC use was that there was no additional survival advan-
tage gained from a more detailed knowledge of haemodynamics,
and this was particularly true when there was no protocol driven
management strategy associated with that information. Similarly,
the new devices need careful scrutiny before they replace the PAC
as another unevaluated ’reference standard’, especially when they
only serve as diagnostic tools.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by year of study]
Shoemaker 1988
Methods Randomized by cards arranged according to random numbers tables, by an outside
person, placed in sealed opaque envelopes opened in sequence
Participants Entry criteria:
patients with one or more of 11 high risk criteria previously defined and associated with
a mortality rate close to 30%.
Exclusion criteria:
none stated.
Interventions PAC standard group (n = 30) - transfer to ICU. PAC placed followed by standard
management to achieve normal values of haemodynamic and oxygen transport variables
PAC protocol group (n = 28) - transfer to ICU, PAC placed followed by treatment to
achieve supra-normal haemodynamic and oxygen transport values.
Control group (n = 30) - CVC placed. Standard care. Not reported if managed in ICU
preoperatively
Outcomes Mortality andmorbidity (statistic not specified).Main outcome not stated. Also reported
ICU and hospital LOS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Two series of patients in both groups and
number of patients were not randomized.
Series one randomization was not clear, se-
ries 2, some patients were randomized post-
operatively, some preoperatively and some
are not randomized
Allocation concealment (selection bias) Low risk Designated by cards arranged according to
a random number table by an outside per-
son, placed in opaque sealed envelope
Blinding of participants and personnel
(performance bias)
primary outcome
High risk Not blinded, but providers were rotated in
both control and treatment groups
Blinding of outcome assessment (detection
bias)
primary outcome
High risk Not blinded
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Shoemaker 1988 (Continued)
Incomplete outcome data (attrition bias)
alloutcomes
Low risk All outcome data are reported
Selective reporting (reporting bias) Low risk Reported all outcome data
Other bias High risk Series 1 had high-risk surgical patients and
series 1 had low-risk surgical patients, but
when physicians felt some patients were
not candidates for invasivemonitoring they
were excluded from the study or included
postoperatively
Pearson 1989
Methods Randomized using a table of random numbers (no other details given)
Participants Entry criteria:
scheduled for elective cardiac surgery.
Exclusion criteria:
none given.
Interventions PAC 1 group (n = 86) - standard PAC placed.
PAC 2 group (n = 66) - mixed venous oxygen measuring PAC placed.
Control group (n = 74) - CVC placed.
Outcomes ICU mortality
ICU LOS
Costs of care. Main outcome not stated.
Notes Of the 74 patients randomized to the control group, 46 were reassigned following ran-
domizations to one of the PAC groups for “ethical” reasons
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk 46 patients were reassigned to PAC after
randomization
Allocation concealment (selection bias) Low risk Used a table of random numbers
Blinding of participants and personnel
(performance bias)
primary outcome
High risk Not blinded in fact allowed to change the
group after randomizations
Blinding of outcome assessment (detection
bias)
primary outcome
High risk No blinding done
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Pearson 1989 (Continued)
Incomplete outcome data (attrition bias)
alloutcomes
Low risk Reported all the cost, LOS and mortality
outcomes
Selective reporting (reporting bias) Low risk None
Other bias High risk Additional groups 4 and 5 were included
due to reassignment of groups after ran-
domizations can cause unknown bias
Joyce 1990
Methods Preoperative randomization into two groups.
Participants Entry criteria:
elective infra-renal aortic reconstructive surgery.
Exclusion criteria:
unstable angina; recent myocardial infarction (last 6 months); left ventricular ejection
fraction less than 50%
Interventions PAC group (n = 21) - PAC placed (no management protocol).
Control group (n = 19) - CVC placed (no management protocol)
Outcomes Main outcome was postoperative cardiac complications (defined). Also reported 30-day
postoperative mortality
Notes A non-randomized group (n = 11) were included in the analyses
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Used “sealed envelope technique”
Allocation concealment (selection bias) Low risk Sealed envelopes are concealed allocation
Blinding of participants and personnel
(performance bias)
primary outcome
Unclear risk Insufficient information to judge
Blinding of outcome assessment (detection
bias)
primary outcome
Unclear risk Insufficient information to judge
Incomplete outcome data (attrition bias)
alloutcomes
Low risk Reported all data
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Joyce 1990 (Continued)
Selective reporting (reporting bias) Low risk Reported all outcomes
Other bias Low risk None
Isaacson 1990
Methods Randomized using marked cards.
Participants Entry criteria:
elective aortic reconstructive surgery.
Exclusion criteria:
uncorrectable coronary artery disease; cor pulmonale; severe heart failure; cardiomyopa-
thy; left ventricular ejection fraction less than 40%; symptomatic valvular disease; renal
failure; severe restrictive/obstructive pulmonary disease
Interventions PAC group (n = 49) - PAC placed before induction of general anaesthesia.
Control group (n = 53) - CVC placed before induction of general anaesthesia
Outcomes Hospital mortality, ICU LOS, hospital LOS, costs of care. Main outcome not stated
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Used marked cards, shuffled
Allocation concealment (selection bias) Low risk Used faced down cards and made sure investigator
would not know which monitor patient would re-
ceive
Blinding of participants and personnel
(performance bias)
primary outcome
High risk Not blinded same group who did the study made
the patient care decision as well
Blinding of outcome assessment (detection
bias)
primary outcome
High risk Not blinded
Incomplete outcome data (attrition bias)
alloutcomes
Low risk No missing out come data
Selective reporting (reporting bias) Low risk Followed prespecified protocol
Other bias Low risk None
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Guyatt 1991
Methods Randomization blocked according to a computer-generated list of random numbers in
groups of four for each unit. Participating physicians were not aware of the blocking.
Envelopes were prepared in sequential order for each unit and were checked daily
Participants Entry criteria:
assisted ventilation;
hypotension with CVP of 10cm H2O or more;
oliguria with CVP 10cm H2O or more;
oliguria with hypoxaemia;
hypoxaemia and CVP less than 10cm H2O;
physician believed patient might benefit from a PAC.
Exclusion criteria:
PAC ethically contraindicated;
PAC an ethical imperative;
PAC placed preoperatively for intraoperative monitoring;
organ transplant surgery;
receiving high frequency jet ventilation;
consent from a close relative not obtained.
Interventions PAC group (n = 16) - PAC placed and used at the discretion of the attending physician
(no management protocol).
Control group (n = 17) - standard care without a PAC.
Outcomes Main outcome mortality (mortality statistic not specified). Secondary outcome ICU
LOS
Notes Trial stopped early because of poor recruitment.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated sequence
Allocation concealment (selection bias) Low risk Physicians were not aware of blocks and
used envelopes
Blinding of participants and personnel
(performance bias)
primary outcome
High risk Not blinded and allowed to cross-over to
PAC group
Blinding of outcome assessment (detection
bias)
primary outcome
High risk Not blinded and allowed to change the
group if physician felt ethically need PAC
Incomplete outcome data (attrition bias)
alloutcomes
Low risk Reported all data including cross-over data
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Guyatt 1991 (Continued)
Selective reporting (reporting bias) Low risk Reported all outcomes
Other bias High risk High risk of contaminating the random-
ized group by allowing the sicker patients
to cross-over to PAC group may have con-
tributed to high mortality reported
Berlauk 1991
Methods Randomized using random number generator. Patients entered consecutively in order
of appearance on the surgical schedule. No other details given
Participants Entry criteria: scheduled to receive an in situ vein graft bypass for lower limb vascular
insufficiency. Exclusion criteria: myocardial infarction within 3 months; coronary artery
bypass graft within 6 weeks; uncompensated congestive heart failure; severe valvular
disease; unstable angina
Interventions PAC 1 group (n = 45) - transfer to ICU, PAC placed followed by “tune-up” treatment
(using predefined end points) at least 12 hrs preoperatively.
PAC 2 group (n = 23) - transfer to anaesthetic holding area, PAC placed followed by
“tune-up” treatment (using predefined end points) at least 3 hrs preoperatively.
Control group (n = 21) usual care without a PAC. Arterial catheters and CVCs placed
Outcomes Main outcome cardiovascular complications. Secondary outcomes were immediate post-
operative graft thrombosis and adverse intra-operative events. Also reported mortality
(not specified), ICU LOS, hospital LOS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Used random number generator (Stat-
works)
Allocation concealment (selection bias) Unclear risk Eligible patients were entered consecutively
in order of the surgical schedule, no central
allocation used, anaesthesiologist may have
foreseen allocation while screening for eli-
gibility
Blinding of participants and personnel
(performance bias)
primary outcome
Unclear risk Appears to be the study group treated the
patients postoperatively
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Berlauk 1991 (Continued)
Blinding of outcome assessment (detection
bias)
primary outcome
Low risk Anesthesioloist cared for initial 18 hours
and unlikely to influence LOS and mortal-
ity
Incomplete outcome data (attrition bias)
alloutcomes
Low risk Reported all outcome data
Selective reporting (reporting bias) Low risk Reported all predefined outcome data
Other bias Low risk None
Bender 1997
Methods Randomized but methods not described.
Participants Entry criteria: scheduled for elective infrarenal aortic reconstruction or lower limb revas-
cularize (by a single surgeon). Exclusion criteria: anticipated need before surgery for
suprarenal or supra-coeliac aortic clamping; myocardial infarction within 3 months or
inadequately controlled angina; poorly compensated congestive heart failure; coronary
artery bypass surgery within 6 weeks; symptomatic aortic/mitral valvular disease
Interventions PAC group (n = 51) - transfer to ICU, PAC placed followed by “optimizations” preop-
eratively using a treatment algorithm.
Control group (n = 53) - standard care without a PAC. Arterial catheter and CVC placed
Outcomes Adverse outcomes (defined) including 30-day mortality, ICU LOS, hospital LOS. Main
outcome not stated
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Patients were assigned randomly by the sur-
gical intensivist
Allocation concealment (selection bias) High risk Intensivist assigned patients, not concealed
at all
Blinding of participants and personnel
(performance bias)
primary outcome
High risk Not blinded. Patients were chosen.
Blinding of outcome assessment (detection
bias)
primary outcome
High risk Same physician analysed data and cared for
all patients, not blinded for any outcome
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Bender 1997 (Continued)
Incomplete outcome data (attrition bias)
alloutcomes
Unclear risk Did not report about patients who did not
get PAC postoperatively in group 2
Selective reporting (reporting bias) High risk Postoperative non-PA catheter group data
is not reported and no tables or number of
patients
Other bias High risk One surgical intensivist cared for all 104 pa-
tients reported and the unreported group of
patients for the LOS of 27 days at times re-
ported is likely to create several unknown
bias
Valentine 1998
Methods Randomized using sealed envelopes. No other details given.
Participants Entry criteria:
elective abdominal aortic reconstruction.
Exclusion criteria:
myocardial infarction within 3 months; coronary artery bypass surgery within 6 weeks;
severe aortic/mitral valve disease; unstable angina/recent change in angina symptoms;
clinically overt congestive cardiac failure; advanced chronic renal insufficiency; repeat
aortic operations; additional procedures, e.g. renal artery bypass grafting performed
Interventions PAC group (n = 60) - transfer to ICU, PAC placed followed by “tune-up” treatment
(using predefined end points used be Berlauk et al) at least 14 hrs preoperatively.
Control group (n = 60) not transferred to ICU, CVC placed and no specific preoperative
treatment
Outcomes Adverse postoperative events (defined), duration of ventilation,
ICU LOS and hospital LOS, hospital mortality.
Main outcome not stated.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Used sealed envelopes
Allocation concealment (selection bias) Unclear risk Not mentioned how allocation was done
Blinding of participants and personnel
(performance bias)
primary outcome
Unclear risk Not mentioned if the study group also
treated the patients
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Valentine 1998 (Continued)
Blinding of outcome assessment (detection
bias)
primary outcome
Unclear risk Not mentioned study reviewers were
blinded from knowing or altering the out-
come
Incomplete outcome data (attrition bias)
alloutcomes
Low risk Reported all predefined outcome data
Selective reporting (reporting bias) Low risk No selective reporting
Other bias Low risk Two control group patients were trans-
ferred over to PAC but did not include
them in analysis
Rhodes 2002
Methods Randomized using computer generated random numbers stored in sealed envelopes
Participants Entry criteria:
either circulatory shock (definition given); oliguria (definition given); requirement for
vasoactive infusion; need for mechanical ventilation.
Exclusion criteria:
less than 18 yrs of age; admitted to ICU for preoperative optimizations
Interventions PAC group (n = 96) - PAC placed (no management protocol).
Control group (n = 105) - standard care without a PAC or any other form of cardiac
output monitoring
Outcomes Main outcome 28-day mortality.
Secondary outcomes ICU LOS, hospital LOS and morbidity.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quirk of computer generated sequence
Allocation concealment (selection bias) Low risk Sealed envelopes
Blinding of participants and personnel
(performance bias)
primary outcome
Low risk Double blinding of the study was not fea-
sible, but treating physicians were not pre-
localized to follow a path, allowed to treat
clinically and remove PAC if felt the need
does not exist, less likely to influence the
outcome
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Rhodes 2002 (Continued)
Blinding of outcome assessment (detection
bias)
primary outcome
Low risk Study outcome assessment was done later
on and treating physicians were not given
instructions to follow a protocol and end
result
Incomplete outcome data (attrition bias)
alloutcomes
Low risk All data are reported including the PAC
group who did not get the catheter, in-
cluded in the analysis
Selective reporting (reporting bias) Low risk None
Other bias Low risk Well covered without any bias
Sandham 2003
Methods Randomized using computer generated sequence concealed in sealed, opaque consecu-
tively numbered envelopes. Stratified according to type of surgery, ASA class and blocked
according to centre
Participants Entry criteria:
Age >60; American Society of Anesthesiologists class III or IV risk; scheduled for urgent/
elective major abdominal, thoracic, vascular or orthopaedic surgery.
Exclusion criteria: none stated.
Interventions PAC group (n = 997) - PAC placed prior to surgery, followed by treatment directed to
predefined physiological goals.
Control group (n = 997) - standard care without a PAC. Placement of CVC permitted
Outcomes Main outcome hospital mortality. Secondary outcome hospital LOS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated sequence
Allocation concealment (selection bias) Low risk Sealed envelopes used
Blinding of participants and personnel
(performance bias)
primary outcome
Low risk Single blind, not double, not feasible but
largemulticentre trial unlikely to introduce
bias
Blinding of outcome assessment (detection
bias)
primary outcome
Low risk Blinded assessment of outcome done
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Sandham 2003 (Continued)
Incomplete outcome data (attrition bias)
alloutcomes
Low risk None
Selective reporting (reporting bias) Low risk Well reported
Other bias Low risk None
Richard 2003
Methods Randomized using 24-hour, 7 day-a-week, central telephone service
Participants Entry criteria:
circulatory shock (definition given) for less than 12 hours and/or acute respiratory distress
syndrome (definition given) for more than 24 hours.
Exclusion criteria:
less than18 years; haemorrhagic shock;myocardial infarction complicated by cardiogenic
shock; thrombocytopaenia (platelets <10,000 mm-3); participated in other trials in the
last 30 days; were moribund; physician refused to agree with use of full life support
Interventions PAC group (n = 335) - PAC placed (no management protocol).
Control group (n = 341) - standard care without a PAC.
Outcomes Main outcome 28-day mortality.
Secondary outcomes 14-day mortality,
90-day mortality,
ICU LOS, hospital LOS.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Permuted block algorithm with stratifica-
tion of each centre
Allocation concealment (selection bias) Low risk Central randomizations by telephone 24
hours a day 7 days a week
Blinding of participants and personnel
(performance bias)
primary outcome
Low risk No standardized protocols and analysis was
not done by treating physicians
Blinding of outcome assessment (detection
bias)
primary outcome
Low risk Outcome assessment was blinded to study
personal and unbinding of others is not
likely to induce bias, multi-entered nature
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Richard 2003 (Continued)
Incomplete outcome data (attrition bias)
alloutcomes
Low risk None missing
Selective reporting (reporting bias) Low risk Reported specifically
Other bias Low risk None
Harvey 2005
Methods Randomized using a 24-hour, 7 day-a-week, central telephone randomization service
and minimized by unit, age group, presumptive clinical syndrome, surgical status
Participants Entry criteria: deemed to require management with a PAC by the treating clinician.
Exclusion criteria: less than 16 years; admitted electively for preoperative optimizations;
PAC already in situ on admission to ICU; previously enrolled into the trial; declared
brain dead with PAC placed prior to organ donation
Interventions PAC group (n = 506) - PAC placed (no management protocol).
Control (n = 508) - standard care without a PAC but with the option to use alternative
cardiac output monitoring devices if the unit had opted to be in stratum B
Outcomes Primary outcome hospital mortality. Secondary outcomes ICU LOS, hospital LOS,
organ-days of support in ICU, costs of care
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Minimization was described
Allocation concealment (selection bias) Low risk Used a central 24 hour telephone service
Blinding of participants and personnel
(performance bias)
primary outcome
Low risk Not blinded, not likely influence the results
due to multicentre trial and investigators
are not providers
Blinding of outcome assessment (detection
bias)
primary outcome
Low risk Investigators were blinded
Incomplete outcome data (attrition bias)
alloutcomes
Low risk None
Selective reporting (reporting bias) Low risk None
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Harvey 2005 (Continued)
Other bias Low risk None
NHLBI 2006
Methods Randomized multicentre factorial study, patients with acute lung injury for 48 hours or
less, randomly assigned in permuted blocks of eight to receive a PAC or a CVC with the
use of an automated system
Patients were simultaneously randomly assigned to a strategy of either liberal or conser-
vative use of fluids guided by a protocol
Participants Inclusion criteria: patients receiving positive pressure ventilation by tracheal tube and
had a ratio of the partial pressure of arterial oxygen (PaO2) to the fraction of inspired
oxygen (FiO2) below 300 and bilateral infiltrates on chest radiography consistent with
the presence of pulmonary edema not due to left atrial hypertension
Exclusion criteria: presence of a PA catheter after the onset of acute lung injury, presence of
acute lung injury for more than 48 hours, inability to obtain consent, presence of chronic
conditions that could independently impair survival or weaning or compliance with
protocol such as dialysis, severe lung or neuromuscular disease, irreversible conditions
and estimated six month mortality rate exceeded 50% such as cancer
Interventions All patients received low tidal volume ventilation according to ARDS network protocol
within one hour after randomizations and continued until day 28 or until breathing
without assistance
PAC or CVC was inserted within 4 hours after randomizations. Haemodynamic man-
agement as dictated by the protocol was started within the next 2 hours and continued
for 7 days or until 12 hours after the patient was able to breathe without assistance. PAC
was allowed to be replaced by a CVC if haemodynamic stability defined by the absence
of protocol directed interventions for > than 24 hours was achieved after day 3
Outcomes Four main protocol variables were measured. Blood pressure and urinary output guided
management was in both groups. PAOP and CI in the PAC group and CVP and clinical
assessment (skin temperature and appearance, rate of capillary refilling) in the CVC
group guided management. Outcome measures were reversal of hypotension, oliguria
and ineffective circulation. Fluid therapy either crystalloids or colloids and vasopressors
were used as per the judgement of the physician, but weaning from vasopressors was
done as per protocol
Notes Lactate levels, mixed venous or superior vena cava oxygen saturation were not used
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Used an automated system in permuted
blocks of eight
Allocation concealment (selection bias) Unclear risk Not mentioned
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NHLBI 2006 (Continued)
Blinding of participants and personnel
(performance bias)
primary outcome
High risk Not blinded
Blinding of outcome assessment (detection
bias)
primary outcome
High risk Not blinded
Incomplete outcome data (attrition bias)
alloutcomes
Low risk Only one lost to follow-up in control group
Selective reporting (reporting bias) Low risk Published reports included all outcomes
Other bias High risk Two different randomizations were done
simultaneously (conservative and liberal
fluid therapy and PAC versus CVC)
PAC - pulmonary artery catheter
CVC - central venous catheter
CVP - central venous pressure
LOS - length of stay
ICU - intensive care unit
FACTT - Fluid And Catheter Treatment Trial
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bach 1992 Not an RCT of management with PAC compared with management without a PAC
Barone 2001 Review and meta-analysis
Boldt 1995 Not an RCT of management with PAC compared with management without a PAC
Bonazzi 2002 Patients assigned to the control group were not transferred to ICU of HDU following surgery
Boyd 1993 Not an RCT of management with PAC compared with management without a PAC
Brazzi 1995 Not an RCT of management with PAC compared with management without a PAC
Cobb 1992 Not an RCT of management with PAC compared with management without a PAC
Cohen 1998 Not an RCT of management with PAC compared with management without a PAC
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(Continued)
Eyer 1990 Not an RCT of management with PAC compared with management without a PAC
Girbes 1999 Study end point was the commencement of surgery
Holmes 1997 Not an RCT
Kearns 1993 Summary of a previously reported RCT
Latour-Perez 1997 Not an RCT
Mermel 1991 Not an RCT
Mitchell 1992 Not an RCT of management with PAC compared with management without a PAC
Orlando 1985 Conference abstract only
Raybin 1989 Letter
Schultz 1985 Not all patients assigned to the control group were transferred to ICU or HDU following surgery
Senagore 1987 Not an RCT of management with a PAC compared with management without PAC
Shoemaker 1990 Patients were randomly allocated in the second part of the study only. In addition, there was no clear data on
mortality in the two groups
Sola 1993 Review article
Stewart 1998 Not an RCT
Stout 2006 Randomized part of this trial is to be cardiac output (CO) (indocyanine green (ICG)) or not and didn’t include
PACs. PACs and CO (TD) are only referred to in the literature review part of the study
Stubbig 1992 Not an RCT of management with PAC compared with management without a PAC
Suttner 2006 Not an RCT, PAC compared with thoracic electrical bioimpedance, non-invasive method
Takala 2011 Not an RCT of use of PACs - both groups had some use of PAC, the randomization was to MICO or not
Tuman 1989 Not an RCT
Wilson 1999 Not all patients assigned to the control group were transferred to ICU or HDU following surgery
Yu 1993 Not an RCT of management with PAC compared with management without a PAC
Yu 1995 Not an RCT of management with PAC compared with management without a PAC
Yu 2011 Tested the intervention of blood volume measurement and both groups had PACs
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Ziegler 1997 Not an RCT of management with PAC compared with management without a PAC
ICU - intensive care unit
HDU - high dependency unit
MICO - minimally invasive cardiac output
PAC - pulmonary artery catheter
RCT - randomized controlled trial
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D A T A A N D A N A L Y S E S
Comparison 1. Combined mortality: PAC versus no PAC
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Combined mortality of all
studies
13 5686 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.95, 1.08]
Comparison 2. PAC versus no PAC
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All types mortality (general
intensive care patients)
5 2923 Risk Ratio (M-H, Random, 95% CI) 1.02 [0.96, 1.09]
2 All types mortality (high-risk
surgical patients)
8 2763 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.74, 1.29]
2.1 All types mortality (studies
of perioperative monitoring
including pre-operative
optimization)
5 2395 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.74, 1.29]
2.2 All types mortality (studies
of perioperative monitoring)
3 368 Risk Ratio (M-H, Random, 95% CI) 1.10 [0.14, 8.82]
Comparison 3. ICU length of stay PAC versus no PAC
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 ICU length of stay (general
intensive care patients)
4 2723 Mean Difference (IV, Random, 95% CI) 0.15 [-0.74, 1.03]
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Comparison 4. Hospital length of stay: PAC versus no PAC
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Hospital length of stay (general
intensive care patients)
2 1689 Mean Difference (IV, Random, 95% CI) -0.80 [-2.71, 1.12]
2 Hospital length of stay (high-risk
surgical patients)
5 503 Mean Difference (IV, Random, 95% CI) 0.35 [-0.05, 0.75]
Comparison 5. Cost of care: PAC versus no PAC
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Cost of care (hospital charges,
1000’s of US dollars)
2 191 Mean Difference (IV, Fixed, 95% CI) 0.90 [-2.62, 4.42]
Analysis 1.1. Comparison 1 Combined mortality: PAC versus no PAC, Outcome 1 Combined mortality of
all studies.
Review: Pulmonary artery catheters for adult patients in intensive care
Comparison: 1 Combined mortality: PAC versus no PAC
Outcome: 1 Combined mortality of all studies
Study or subgroup PAC Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Bender 1997 1/51 1/53 0.1 % 1.04 [ 0.07, 16.18 ]
Berlauk 1991 1/68 2/21 0.1 % 0.15 [ 0.01, 1.62 ]
Guyatt 1991 10/16 9/17 1.1 % 1.18 [ 0.66, 2.12 ]
Harvey 2005 346/506 337/507 53.6 % 1.03 [ 0.94, 1.12 ]
Isaacson 1990 1/49 0/53 0.0 % 3.24 [ 0.14, 77.71 ]
Joyce 1990 0/21 0/19 Not estimable
NHLBI 2006 140/513 128/487 9.3 % 1.04 [ 0.85, 1.27 ]
Pearson 1989 1/152 1/74 0.1 % 0.49 [ 0.03, 7.68 ]
0.01 0.1 1 10 100
Favours experimental Favours control
(Continued . . . )
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(. . . Continued)
Study or subgroup PAC Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Rhodes 2002 46/96 50/105 4.7 % 1.01 [ 0.75, 1.34 ]
Richard 2003 199/335 208/341 26.1 % 0.97 [ 0.86, 1.10 ]
Sandham 2003 78/997 77/997 4.3 % 1.01 [ 0.75, 1.37 ]
Shoemaker 1988 11/58 7/30 0.6 % 0.81 [ 0.35, 1.88 ]
Valentine 1998 3/60 1/60 0.1 % 3.00 [ 0.32, 28.03 ]
Total (95% CI) 2922 2764 100.0 % 1.01 [ 0.95, 1.08 ]
Total events: 837 (PAC), 821 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 5.26, df = 11 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 0.41 (P = 0.68)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 2.1. Comparison 2 PAC versus no PAC, Outcome 1 All types mortality (general intensive care
patients).
Review: Pulmonary artery catheters for adult patients in intensive care
Comparison: 2 PAC versus no PAC
Outcome: 1 All types mortality (general intensive care patients)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Guyatt 1991 10/16 9/17 1.2 % 1.18 [ 0.66, 2.12 ]
Harvey 2005 346/506 333/507 56.0 % 1.04 [ 0.95, 1.14 ]
NHLBI 2006 (1) 140/513 128/487 9.9 % 1.04 [ 0.85, 1.27 ]
Rhodes 2002 46/96 50/105 5.0 % 1.01 [ 0.75, 1.34 ]
Richard 2003 199/335 208/341 27.8 % 0.97 [ 0.86, 1.10 ]
Total (95% CI) 1466 1457 100.0 % 1.02 [ 0.96, 1.09 ]
Total events: 741 (Treatment), 728 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.04, df = 4 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 0.64 (P = 0.52)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours treatment Favours control
(1) 60 day mortality calculated number of events from the percent reported 27.4% for PAC and 26.3% for CVC
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Analysis 2.2. Comparison 2 PAC versus no PAC, Outcome 2 All types mortality (high-risk surgical patients).
Review: Pulmonary artery catheters for adult patients in intensive care
Comparison: 2 PAC versus no PAC
Outcome: 2 All types mortality (high-risk surgical patients)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 All types mortality (studies of perioperative monitoring including pre-operative optimization)
Berlauk 1991 1/68 2/21 1.4 % 0.15 [ 0.01, 1.62 ]
Shoemaker 1988 11/58 7/30 10.8 % 0.81 [ 0.35, 1.88 ]
Sandham 2003 78/997 77/997 83.5 % 1.01 [ 0.75, 1.37 ]
Bender 1997 1/51 1/53 1.0 % 1.04 [ 0.07, 16.18 ]
Valentine 1998 3/60 1/60 1.5 % 3.00 [ 0.32, 28.03 ]
Subtotal (95% CI) 1234 1161 98.2 % 0.98 [ 0.74, 1.29 ]
Total events: 94 (Treatment), 88 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.58, df = 4 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.15 (P = 0.88)
2 All types mortality (studies of perioperative monitoring)
Joyce 1990 0/21 0/19 Not estimable
Pearson 1989 1/152 1/74 1.0 % 0.49 [ 0.03, 7.68 ]
Isaacson 1990 1/49 0/53 0.8 % 3.24 [ 0.14, 77.71 ]
Subtotal (95% CI) 222 146 1.8 % 1.10 [ 0.14, 8.82 ]
Total events: 2 (Treatment), 1 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.79, df = 1 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 0.09 (P = 0.93)
Total (95% CI) 1456 1307 100.0 % 0.98 [ 0.74, 1.29 ]
Total events: 96 (Treatment), 89 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 4.37, df = 6 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 0.13 (P = 0.89)
Test for subgroup differences: Chi2 = 0.01, df = 1 (P = 0.91), I2 =0.0%
0.01 0.1 1 10 100
Favours treatment Favours control
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Analysis 3.1. Comparison 3 ICU length of stay PAC versus no PAC, Outcome 1 ICU length of stay (general
intensive care patients).
Review: Pulmonary artery catheters for adult patients in intensive care
Comparison: 3 ICU length of stay PAC versus no PAC
Outcome: 1 ICU length of stay (general intensive care patients)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Guyatt 1991 16 10.3 (0) 17 8.1 (0) Not estimable
Harvey 2005 506 10.7 (16.1) 508 10.7 (20.1) 15.7 % 0.0 [ -2.24, 2.24 ]
NHLBI 2006 513 12.5 (11.32) 487 12 (8.82) 50.0 % 0.50 [ -0.75, 1.75 ]
Richard 2003 335 11.6 (10.1) 341 11.9 (10) 34.3 % -0.30 [ -1.82, 1.22 ]
Total (95% CI) 1370 1353 100.0 % 0.15 [ -0.74, 1.03 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.66, df = 2 (P = 0.72); I2 =0.0%
Test for overall effect: Z = 0.33 (P = 0.74)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours treatment Favours control
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Analysis 4.1. Comparison 4 Hospital length of stay: PAC versus no PAC, Outcome 1 Hospital length of stay
(general intensive care patients).
Review: Pulmonary artery catheters for adult patients in intensive care
Comparison: 4 Hospital length of stay: PAC versus no PAC
Outcome: 1 Hospital length of stay (general intensive care patients)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Harvey 2005 506 22.9 (34.3) 507 26.1 (45.4) 14.2 % -3.20 [ -8.15, 1.75 ]
Richard 2003 335 14 (11.6) 341 14.4 (11.3) 85.8 % -0.40 [ -2.13, 1.33 ]
Total (95% CI) 841 848 100.0 % -0.80 [ -2.71, 1.12 ]
Heterogeneity: Tau2 = 0.34; Chi2 = 1.09, df = 1 (P = 0.30); I2 =9%
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours treatment Favours control
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Analysis 4.2. Comparison 4 Hospital length of stay: PAC versus no PAC, Outcome 2 Hospital length of stay
(high-risk surgical patients).
Review: Pulmonary artery catheters for adult patients in intensive care
Comparison: 4 Hospital length of stay: PAC versus no PAC
Outcome: 2 Hospital length of stay (high-risk surgical patients)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bender 1997 51 12.5 (1.4) 53 12 (1.3) 58.9 % 0.50 [ -0.02, 1.02 ]
Berlauk 1991 68 18.93 (11.8) 21 15.4 (7.5) 0.9 % 3.53 [ -0.73, 7.79 ]
Isaacson 1990 49 10.2 (8.4) 53 9.4 (6.8) 1.8 % 0.80 [ -2.18, 3.78 ]
Shoemaker 1988 58 22.35 (4.18) 30 22.2 (2.8) 7.4 % 0.15 [ -1.32, 1.62 ]
Valentine 1998 60 13 (2) 60 13 (2) 31.1 % 0.0 [ -0.72, 0.72 ]
Total (95% CI) 286 217 100.0 % 0.35 [ -0.05, 0.75 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.54, df = 4 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 1.72 (P = 0.085)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours treatment Favours control
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Analysis 5.1. Comparison 5 Cost of care: PAC versus no PAC, Outcome 1 Cost of care (hospital charges,
1000’s of US dollars).
Review: Pulmonary artery catheters for adult patients in intensive care
Comparison: 5 Cost of care: PAC versus no PAC
Outcome: 1 Cost of care (hospital charges, 1000’s of US dollars)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Berlauk 1991 68 27.3 (0) 21 23.4 (12.3) Not estimable
Isaacson 1990 49 16.7 (9.1) 53 15.8 (9) 100.0 % 0.90 [ -2.62, 4.42 ]
Total (95% CI) 117 74 100.0 % 0.90 [ -2.62, 4.42 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours treatment Favours control
A P P E N D I C E S
Appendix 1. Search strategy for CENTRAL, The Cochrane Library
#1 MeSH descriptor Catheterization, Swan-Ganz explode all trees
#2 MeSH descriptor Heart Catheterization explode all trees
#3 pulmonary artery catheter*
#4 (pulmonary arter*) near (flotation or cathet*)
#5 (right heart) near catheter*
#6 right-heart near catheter*
#7 swan-ganz near catheter*
#8 swanganz near catheter*
#9 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8)
#10 MeSH descriptor Critical Care explode all trees
#11 MeSH descriptor Intensive Care Units explode all trees
#12 (intensiv* or critical or postanesthesia or postanaesthesia) near care
#13 high dependency unit*
#14 (#10 OR #11 OR #12 OR #13)
#15 (#9 AND #14)
51Pulmonary artery catheters for adult patients in intensive care (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Appendix 2. Search strategy for MEDLINE (OvidSP)
1 . expCatheterization-Swan-Ganz/ or Heart-Catheterization/ or pulmonary art?ery catheter*.ti,ab. or (pulmonary arter* adj5 (flotation
or cathet*)).mp. or (right?heart and catheter*).mp. or swan?ganz*.ti,ab.
2 . exp Critical care/ or exp Intensive-Care-Units/ or critical care unit*.mp. or ((intensiv* or critical or post?an?esthesia) adj5 care
unit).mp. or high dependency unit*.mp. or critical care.ti,ab.
3 . 1 and 2
4 . (adolescent* or child* or preschool* or infant* or newborn).mp.
5 . Adult.mp.
6 . 4 not (5 and 4)
7 . 3 not 6
8 . ((randomised controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or drug therapy.fs. or randomly.ab. or
trial.ab. or groups.ab.) not (animals not (humans and animals)).sh.
9 . 7 and 8
Appendix 3. Search strategy for EMBASE (OvidSP)
1 . exp swan-ganz-catheter/ or exp heart-catheterization/ or pulmonary art?ery catheter*.ti,ab. or (pulmonary arter* adj5 (flotation or
cathet*)).mp. or (right?heart and catheter*).mp. or swan?ganz*.ti,ab. (
2 . exp intensive-care/ or critical care unit*.mp. or ((intensiv* or critical or post?an?esthesia) adj5 care unit).mp. or high dependency
unit*.mp. or critical care.ti,ab.
3 . 1 and 2
4 . (placebo.sh. or controlled study.ab. or random*.ti,ab. or trial*.ti,ab. or ((singl* or doubl* or trebl* or tripl*) adj3 (blind* or
mask*)).ti,ab.) not (animals not (humans and animals)).sh.
5 . 3 and 4
Appendix 4. Search strategy for CINAHL (EBSCOhost)
S1 (MM “Swan-Ganz Catheterization”)
S2 (MH “Heart Catheterization+”)
S3 TX pulmonary arter* and TX ( flotation or cathet* )
S4 TX ( swan-ganz or right-heart ) and TX catheter*
S5 S1 or S2 or S3 or S4
S6 (MH “Critical Care”)
S7 (MM “Intensive Care Units”)
S8 TX high dependency unit*
S9 AB ( intensiv* or critical or postanesthesia or postanaesthesia ) and AB care
S10 S6 or S7 or S8 or S9
S11 S5 and S10
Appendix 5. Search strategy for grey literature
Several combinations of the following search terms where used. Truncation was used when available
pulmonary artery catheter random
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(Continued)
pulmonary arterial catheter
pulmonary artery catheterization
pulmonary arterial catheterization
right heart catheterization
swan ganz
randomised
randomizations
randomised
randomizations
Grey Literature Sources
www.nyam.org/library/pages/grey˙literature˙report
NYAM Grey Literature Collection
http://oaister.worldcat.org
OAIster - Digital Resource from Open Archive Collections
www.doaj.org
Directory of Open Access Journals
www.opendoar.org
OpenDOAR
Clinical Trial Registers
www.isrctn.org
Int Standard Randomized Controlled Trial Number Reg
https://www.clinicaltrialsregister.eu
Eur Clin Trials Register
(new 2011)
http://apps.who.int/trialsearch
WHO ICTRP
Dissertations and Theses
www.ndltd.org
Networked Digital Library of Theses and Dissertations
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(Continued)
ProQuest Dissertations & Theses
Open Access Journals
www.doaj.org
Directory of Open Access Journals
www.opendoar.org
OpenDOAR
http://roar.eprints.org
Registry of Open Access Repositories
Meeting Abstracts
http://gateway.nlm.nih.gov/gw/Cmd
Meeting Abstracts thru NLM Gateway
Conference Abstracts (hand-searched in the original review)
European Society of Intensive Care Medicine
Intensive Care Medicine
http://xa.yimg.com/kq/groups/19299193/148298693/name/ISICEM+abstracts+2011.pdf
31st International Symposium on Intensive Care and Emergency medicine
Society of Critical Care Medicine
Critical Care Medicine
American Thoracic Society
The American Journal of Respiratory and Critical Care Medicine
Proceedings of the American Thoracic Society
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Appendix 6. ICU and hospital length of stay
Study ID Measure ICU LOS,
PAC
ICU LOS, no
PAC
P value Hosp LOS,
PAC
Hosp LOS,
no PAC
P value
Guyatt 1991 Mean, days
(survivors)
10.3 8.1 0.58
Rhodes 2002 Median (IQR)
, days (sur-
vivors)
10 (2, 14) 6 (2, 13) 0.27 29 (15, 54) 25 (15, 53) 0.81
Rhodes 2002 Median (IQR)
, days (all pa-
tients)
5.7 (2, 12) 4 (2, 10) 0.47 13 (5, 32) 14 (3, 32) 0.81
Isaacson 1990 Mean
(SD), days (all
patients)
2.7 (2.6) 2.1 (1.0) 0.13 10.2 (8.4) 9.4 (6.8) 0.60
Richard 2003 Mean
(SD), days (all
patients)
11.6 (10.1) 11.9 (10.0) 0.72 14.0 (11.6) 14.4 (11.3) 0.67
Pearson 1989 Mean
(SD), days (all
patients)
PAC 1: 1.6 (1.
1), PAC 2: 2.1
(4.1)
1.35 (1.1)
Bender 1997 Mean
(SD), days (all
patients)
2.7 (0.2) 2.6 (0.5) 12.5 (1.4) 12.0 (1.3)
Berlauk 1991 Mean
(SD), days (all
patients)
PAC 1: 3.5 (2.
0), PAC 2: 2.5
(1.3)
2.6 (2.1) PAC 1: 19.4
(11.6), PAC 2:
18.0 (12.0)
15.4 (7.5)
Sandham
2003
Median (IQR)
, days (all pa-
tients)
10 (7, 15) 10 (7, 15) 0.41
Shoemaker
1988
Mean
(SD), days (all
patients)
PAC con-
trol: 15.8 (3.1)
, PAC proto-
col: 19.3 (2.4)
11.5 (1.7) <0.
05 (PAC pro-
tocol vs PAC
control)
PAC con-
trol: 25.2 (3.4)
, PAC proto-
col: 19.3 (2.4)
22.2 (2.8)
Valentine
1998
Mean
(SD), days (all
patients)
8 (1) 7 (1) 13 (2) 13 (2)
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(Continued)
Harvey 2005 Median (IQR)
, days (sur-
vivors)
12.1 (6.2, 22.
3)
11.0 (5.7, 21.
0)
0.26 34 (23, 61) 40 (21, 70) 0.43
Harvey 2005 Median (IQR)
, days (non-
survivors)
2.6 (0.7, 8.4) 2.5 (0.8, 7.2) 0.71 3 (1, 11) 3 (1, 11) 0.90
NHLBI 2006 Mean
ICU free days
at day 28
12.5 +/-0.5 12.0+/- 0.4 0.40
Appendix 7. Costs of care
Study Measure Cost, PAC 1 Cost, PAC 2 Cost, no PAC P value
Isaacson 1990 Mean (SD) total
hospital charges per
patient
$16,680 (9,108) N/A $15,813 (9,028)
Isaacson 1990 Mean (SD) Anesthe-
siologists fee per pa-
tient
$1,739 (225) N/A $1,551 (252) 0.0001
Pearson 1989 Mean (SD)
total costs (billed to
patient)
$855.51 (231) $1128.38 (759) $591.19 (68)
Berlauk 1991 Mean (SD) total
hospital charges
$29,102 (13,207) $23,770 (12,418) $23,386 (12,303)
Shoemaker 1988 Average (not speci-
fied) hospital charges
PAC control: $37,
335
PAC protocol: $27,
665
$30,748
Stevens 2005 Mean (SEM) total
cost per patient
(converted to US
$, reported in UK
£18,612 for PAC
and £19,211 for no,
PAC Cochrane cost
converter )
$28,677.97 (1627.
12)
$ 29,600.92 (1987.
67)
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WH A T ’ S N E W
Last assessed as up-to-date: 31 January 2012.
Date Event Description
24 April 2012 New citation required and conclusions have changed This review is an update of a previous Cochrane systematic
review (Harvey 2006) that included 12 RCTs. The previous
authors Harvey S, Young D, Brampton W, Cooper A, Doig
GS, Sibbald W and Rowan K decided not to update the
review
In this updated version, we found five new large trials and
chose to include one large trial which met our inclusion
criteria (NHLBI 2006). Additionally three RCTs were ex-
cluded due to a different patient population and end points
(Bonazzi 2002; ESCAPE 2005; Schultz 1985).
In general our review reaches the same conclusions asHarvey
2006. However, we included one large new trial (NHLBI
2006) and thus havemore precise estimates on hospital mor-
tality.We applied several additional sensitivity and subgroup
analyses which supported the overall results. We graded the
quality of evidence of our outcomes. In our discussion we
have cited several additional studies which are both in agree-
ment and disagreement with our results. We have reported
the review with several additional subheadings and back-
ground information. We modified some of the conclusions
24 April 2012 New search has been performed In the previous version (Harvey 2006) the databases were
searched until 2002. In this updated version, we reran the
searches until 31 January 2012. We included risk of bias
tables, graph and summary graph, study flow diagram, fun-
nel plot, grey literature appendix and summary of finding
tables. We have extended our search strategy to include ad-
ditional electronic databases
H I S T O R Y
Protocol first published: Issue 1, 2002
Review first published: Issue 3, 2006
Date Event Description
28 May 2010 Amended Contact details updated.
7 August 2008 Amended Minor edit to text
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31 July 2008 Amended Converted to new review format.
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N Desai (ND): author on meta-analysis, reviewed the papers, drafted the background, edited references in RevMan, added clinical and
consumer perspective in discussion, created summary of finding table and critically revised the report.
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the report.
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